Navigation Links
Pushing the cold frontier in an orderly fashion
Date:9/28/2009

Physicists are continually reaching new lows as they reduce the temperatures of samples in their laboratories. But even nano-kelvins are not low enough to overcome the entropy (a measure of the disorder in a system) that stands between them and the discovery of exotic states of ultra-cold matter. Now physicists at two Italian universities have developed a technique that siphons entropy out of a collection of atoms in much the same way that a kitchen refrigerator removes heat from the food stored inside. The new method is described in Physical Review Letters and highlighted in the September 28 issue of Physics (physics.aps.org).

The system that Jacopo Catani (University of Florence) and colleagues assembled begins with a cloud of potassium and rubidium atoms held in a magnetic trap. They selected a laser with a wavelength of light that interacted with the potassium atoms, but had little effect on the rubidium atoms. They then compressed the potassium atom cloud by focusing the laser to a point in the trap. Compressing a gas usually increases its temperature, but the surrounding rubidium kept things in check, allowing the researchers to hold the temperature roughly constant as entropy was shifted from the potassium to the rubidium atoms.

The novel technique should work with other combinations of atoms as well, offering researchers a new tool to aid them in their pursuit of physics at ultra-low temperatures and entropies.


'/>"/>

Contact: James Riordon
riordon@aps.org
301-209-3238
American Physical Society
Source:Eurekalert  

Page: 1

Related biology technology :

1. DOE awards $377 million in funding for 46 energy frontier research centers
2. Stemline Therapeutics CEO to Present at IBCs New Frontiers in Cancer Drug Development Conference
3. ChanTest Awarded $4.8 Million Through the Ohio Third Frontier Research and Commercialization Program
4. Cordex Pharma Presents New Frontiers in Cardiovascular Medicines on January 29
5. Therapure Biopharma Inc. Announces Manufacturing Agreement with Biomedical Frontiers Incorporated -- Contract will Support Phase II Trials for Thalassemia Treatment
6. The frontiers of nanotechnology
7. SimBioSys Utilizes Revolutionary Hardware Technology to Open New Frontiers in Molecular Modeling
8. Gynecologic Oncologist, With Board Certification in GYN Oncology, OB/GYN, and Surgery Offers Women With Cancer the Newest Treatment Frontier: the Surgical Robot
9. MultiVu Video Feed: Allergan, Inc. Partners With "Project Runway" Designer Kara Saun and Gen Art Fresh Faces In Fashion to Raise Awareness About Excessive Underarm Sweating

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Pushing the cold frontier in an orderly fashion
Pushing the cold frontier in an orderly fashion
(Date:11/19/2009)...Newswire/ - Aegera Therapeutics Inc. announced tod... Phase 2B study of AEG35156, a targeted antisense ...oncology indications. ,, The study, entitled "A...ked Inhibitor of Apoptosis (XIAP) Antisense AEG351...and Idarubicin in AML Following Failure of a Singl...
(Date:11/18/2009)... Marrone Bio Innovations (MBI), a ...lization of effective and environmentally responsi...s been named an IC20 company by the Investors, Cir...l angel investing group. ,, Companies named to ... results for all stakeholders, including investors...
(Date:11/18/2009)...v. 18 Sangamo BioScience... from the University of Pennsylvania investigator ...inger nuclease (ZFN) based product, SB-728-T, for ...sed on the internet. ,, Data were presented in ... School of Medicine from a single subject treated ...
(Date:11/18/2009)...18 /PRNewswire-FirstCall/ - YM BioSciences Inc. (N... development company that identifies and advances ...oducts at various stages of development, announced...were presented today in a poster at the 2009 AACR-...s conference in Boston, Massachusetts. The reporte...
Breaking Biology Technology:Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2Marrone Bio Innovations Named an IC20 Company 2Sangamo BioSciences Provides Update on Phase 1 Safety Trial of SB-728-T for HIV/AIDS 2YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE-NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR-NCI-EORTC MEETING 2YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB RESULTS IN ADVANCED TRIPLE-NEGATIVE BREAST CANCER MODEL PRESENTED AT AACR-NCI-EORTC MEETING 3
...Net Health, a leading allograft bio-implant compan...ple Bunch Tendon, both offering new options for li...new bio-medical implants offer sports medicine phy...njuries. KinetiGraft Tendon and Triple Bunch Tendo...anterior or posterior cruciate ligament, as well a...
...n its flagship,suite of medication and infusion ma... the Pyxis(R) MedStation(R) 4000 and an industry-f...ospitals with customized, actionable,recommendatio...Pyxis(R) MedStation(R) 4000 automated medication d... hospitals increase the security of,high-alert med...
...cal Trial in B-Precursor Acute Lymphoblastic Leuke...nimal Residual Disease , , BETHESDA, Md., Dec...ceutical company developing novel, proprietary ant...and autoimmune diseases, yesterday presented first...E(R) antibody blinatumomab (MT103/MEDI-538) in pat...
Other Biology Technology:LifeNet Health Introduces New Sports Medicine Bio-Implants 2Cardinal Health Launches Pyxis(R) MedStation(R) 4000; Introduces Industry-First Service to Interpret Dispensing and Infusion Data 2Cardinal Health Launches Pyxis(R) MedStation(R) 4000; Introduces Industry-First Service to Interpret Dispensing and Infusion Data 3Data Presented at ASH Annual Meeting Indicates the Potential of T-Cell Engaging BiTE Antibody Blinatumomab as a Consolidation Treatment for Aggressive Leukemias 2Data Presented at ASH Annual Meeting Indicates the Potential of T-Cell Engaging BiTE Antibody Blinatumomab as a Consolidation Treatment for Aggressive Leukemias 3Data Presented at ASH Annual Meeting Indicates the Potential of T-Cell Engaging BiTE Antibody Blinatumomab as a Consolidation Treatment for Aggressive Leukemias 4Data Presented at ASH Annual Meeting Indicates the Potential of T-Cell Engaging BiTE Antibody Blinatumomab as a Consolidation Treatment for Aggressive Leukemias 5
(Date:11/20/2009)...h report published in the November 2009 issue of t... scientists show how a family of genes (1-aminocyc...e responsible for production of ethylene. This gas...is information lays the foundation for future gene...sistant, able to survive and thrive in difficult t...
(Date:11/20/2009)...are invited to contribute their abstracts to the W...10), the largest global meeting devoted to all asp...nd patient care. The Congress will be held in Flor...y, abstracts can be submitted online at http://ww... is February 4, 2010. , IOF and ESCEO are please...
(Date:11/20/2009)... dust: Toxins in coal-tar-based sealcoats in parki...ust, according to a USGS study. PAHs or polycycl...d in oil, coal and tar deposits, and can have toxi...n found in house dust; however, the specific sourc...hers found that dust from indoor areas near parkin...
Breaking Biology News(10 mins):It's a gas: New discovery may lead to heartier, high-yielding plants 2Special sessions announced for World Congress on Osteoporosis 2010 - IOF WCO - ECCEO10 2Special sessions announced for World Congress on Osteoporosis 2010 - IOF WCO - ECCEO10 3From toxic dust and algae to ill winds from Africa 2From toxic dust and algae to ill winds from Africa 3From toxic dust and algae to ill winds from Africa 4From toxic dust and algae to ill winds from Africa 5TrueShred Earns Industrys Highest Security Certification 56311 1NHP to Present at the BMO Capital Markets 2009 North American Real Estate Conference 56307 1Monkey brains signal the desire to explore 9802 1Monkey brains signal the desire to explore 9802 2
...titute of Cardiovascular Disease have identified f...he process of generating new heart cells. The disc...l Nature , provides important new directions on h.... , For decades, scientists were unable to identi... into beating heart cells. Using a clever approach...
...ients with stone disease could benefit from drinki...California, San Francisco suggests that the citrat...y be sufficient to inhibit the development of calc...nnual Scientific Meeting of the American Urologica...roven to augment citraturia, a known factor for ca...
...screws in bridges, fish that listen in the dark, m...e detected comeback of a long-gone whale, the soun...ion can teach us about cowardice. , These are jus...157th meeting of the Acoustical Society of America...n Portland & Executive Tower in Portland, Oregon. ...
Other Biology News:Gladstone scientists identify key factors in heart cell creation 2Laughing hyenas, wailing levees, the sound of cheese and blaring bagpipes 2Laughing hyenas, wailing levees, the sound of cheese and blaring bagpipes 3Laughing hyenas, wailing levees, the sound of cheese and blaring bagpipes 4Laughing hyenas, wailing levees, the sound of cheese and blaring bagpipes 5Laughing hyenas, wailing levees, the sound of cheese and blaring bagpipes 6Laughing hyenas, wailing levees, the sound of cheese and blaring bagpipes 7Laughing hyenas, wailing levees, the sound of cheese and blaring bagpipes 8Laughing hyenas, wailing levees, the sound of cheese and blaring bagpipes 9Laughing hyenas, wailing levees, the sound of cheese and blaring bagpipes 10Laughing hyenas, wailing levees, the sound of cheese and blaring bagpipes 11Laughing hyenas, wailing levees, the sound of cheese and blaring bagpipes 12Laughing hyenas, wailing levees, the sound of cheese and blaring bagpipes 13Laughing hyenas, wailing levees, the sound of cheese and blaring bagpipes 14Laughing hyenas, wailing levees, the sound of cheese and blaring bagpipes 15
Gey's Balanced Salt Solution (GBSS) from Sigma-Aldrich
...cations to the original formulas in efforts to pro...y an important role in tissue,culture. A salt solu...tic balance in the medium and to provide the cells...luable today as when it was first developed a cent...
Ellman's Reagent from Cayman Chemical
Synergy HT Multi-Detection Microplate Reader from BioTek Instruments
Biology Products: